ClinConnect ClinConnect Logo
Search / Trial NCT02339675

Psychometric Properties Upper Limb Function Measures Multiple Sclerosis

Launched by HASSELT UNIVERSITY · Jan 12, 2015

Trial Information

Current as of August 27, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of MS according to McDonald criteria
  • a treatment goal to maintain or improve upper limb function
  • no relapse within the last month
  • no changes in disease modifying medication and no corticoid-therapy within the last month
  • receive at least 10 sessions of physical or occupational therapy (in- or outpatient rehabilitation), with a maximum duration of 3 months
  • Exclusion Criteria:
  • other medical conditions interfering with mobility (e.g. stroke, pregnancy, fractures, ...)
  • other neurological impairments with permanent damage (stroke, Parkinson, ...)
  • MS-like syndromes such as neuromyelitis optica
  • not able to understand and execute simple instructions

About Hasselt University

Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.

Locations

Diepenbeek, , Belgium

Patients applied

0 patients applied

Trial Officials

Peter Feys, prof. dr.

Principal Investigator

Hasselt University

Ilse Baert, dr.

Study Chair

Hasselt University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials